Dolby Laboratories, Inc. DLB
64.83 USD +0.01 (+0.02%)
At closeNov 6, 2026, 4:00 PM EST
64.83 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
63.32 Day range 65.40
48.26 52-week range 69.95
- YTD
- +0.95%
- 1 year
- -0.28%
News
benzinga.com Your Meta AI Glasses Are Getting a Dolby Upgrade Meta expands Dolby Atmos & Vision across AI glasses, Instagram, and VR. Get the tech details and DLB stock forecast here.
benzinga.com Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cycle highs.
benzinga.com AXT Posts Upbeat Q2 Earnings, Joins Newell Brands, SPX Technologies, Amazon And Other Big Stocks Moving Higher On Friday U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other gainers include NWL, FET, IESC, SPXC, AMZN, SPSC, DLB, GH, DXCM, and MPWR.
benzinga.com Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 Est Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 analyst estimate..
benzinga.com Dolby Laboratories Lowers FY2026 Adj EPS Guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.400B-$1.450B to $1.410B-$1.440B vs $1.407B Est Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.410…
benzinga.com Dolby Laboratories Sees Q4 Adj EPS $1.13-$1.28 vs $1.20 Est; Sees Sales $362.000M-$392.000M vs $351.950M Est Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $1.13-$1.28 vs $1.20 analyst estimate. sees sales of $362.000 million-$392.000 million vs $351.950 million analyst estimate.
benzinga.com Dolby Laboratories Q3 Adj. EPS $0.69 Beats $0.67 Estimate, Sales $304.995M Miss $311.960M Estimate Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.67 by 2.99 percent. This is a 11.54 percent decrease over earnings of…
benzinga.com Top 3 Tech Stocks That May Rocket Higher In July Find bargains in oversold IT stocks with RSI values below 30: Fabrinet (NYSE: FN), Dolby Laboratories (NYSE: DLB), Oracle Corp (NYSE: ORCL)
benzinga.com Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on Hormuz news and Trump set 25% EU auto tariffs.
benzinga.com Dolby Laboratories Q2 2026 Earnings Call: Complete Transcript 
benzinga.com 12 Information Technology Stocks Moving In Thursday's After-Market Session - benzinga.com Dolby Laboratories Sees Q3 Adj EPS $0.56-$0.71 vs $0.98 Est; Sees Sales $295.000M-$325.000M vs $343.538M Est Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. sees sales of $295.000 million-$325.000 million vs $343.538 million analyst estimate.
benzinga.com Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.77 Est Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.77 analyst estimate..
benzinga.com Dolby Laboratories Affirms FY2026 Adj EPS Guidance of $4.30-$4.45 vs $4.33 Est; Affirms FY2026 Sales Guidance of $1.400B-$1.450B vs $1.417B Est Dolby Laboratories (NYSE:DLB) affirms FY2026 Adj EPS guidance from $4.30-$4.45 to $4.30-$4.45 vs $4.33 analyst estimate. Affirms FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.400…- benzinga.com Dolby Laboratories Q2 Adj. EPS $1.37 Beats $1.33 Estimate, Sales $395.630M Beat $385.801M Estimate Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.33 by 3.01 percent. This is a 2.24 percent increase over earnings of $1.34…
benzinga.com Earnings Scheduled For April 30, 2026 - benzinga.com Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $90 Price Target Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperform and maintains $90 price target.
- benzinga.com Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $85 Price Target Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $85 price target.
- benzinga.com Dolby Laboratories Raises FY2026 GAAP EPS Guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.78 Est Dolby Laboratories (NYSE:DLB) raises FY2026 GAAP EPS guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.78 analyst estimate..
benzinga.com Dolby Laboratories Raises FY2026 Adj EPS Guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.23 Est; Raises FY2026 Sales Guidance from $1.390B-$1.440B to $1.400B-$1.450B vs $1.406B Est Dolby Laboratories (NYSE:DLB) raises FY2026 Adj EPS guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.23 analyst estimate. Raises FY2026 sales outlook from $1.390 billion-$1.440 billion to $1.400…- benzinga.com Dolby Laboratories Sees Q2 Adj EPS $1.29-$1.44 vs $1.37 Est; Sees Sales $375.000M-$405.000M vs $379.185M Est Dolby Laboratories (NYSE:DLB) is looking for Q2 Adj EPS of $1.29-$1.44 vs $1.37 analyst estimate. sees sales of $375.000 million-$405.000 million vs $379.185 million analyst estimate.
benzinga.com Dolby Laboratories: Q1 Earnings Insights - benzinga.com Dolby Laboratories Q1 Adj. EPS $1.06 Beats $0.88 Estimate, Sales $346.706M Beat $332.073M Estimate Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $0.88 by 20.87 percent. This is a 7.02 percent decrease over earnings of…
- benzinga.com Earnings Scheduled For January 29, 2026
benzinga.com An Overview of Dolby Laboratories's Earnings 
benzinga.com What Analysts Are Saying About Dolby Laboratories Stock - benzinga.com Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $85 Price Target Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $85 price target.
- benzinga.com From Flat To Full Immersion: The AWS Path To Dolby Vision And Dolby Atmos https://aws.amazon.com/blogs/media/from-flat-to-full-immersion-the-aws-path-to-dolby-vision-and-dolby-atmos/
benzinga.com Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $85 Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $95 to $85.- benzinga.com Dolby Laboratories Sees FY2026 Adj EPS $4.19-$4.34 vs $3.96 Est; Sees Sales $1.390B-$1.440B vs $1.347B Est Dolby Laboratories (NYSE:DLB) is looking for FY2026 Adj EPS of $4.19-$4.34 vs $3.96 analyst estimate. sees sales of $1.390 billion-$1.440 billion vs $1.347 billion analyst estimate.
- benzinga.com Dolby Laboratories Sees Q1 Adj EPS $0.79-$0.94 vs $1.14 Est; Sees Sales $315.000M-$345.000M vs $366.956M Est Dolby Laboratories (NYSE:DLB) is looking for Q1 Adj EPS of $0.79-$0.94 vs $1.14 analyst estimate. sees sales of $315.000 million-$345.000 million vs $366.956 million analyst estimate.
- benzinga.com Dolby Laboratories Q4 Adj. EPS $0.99 Beats $0.70 Estimate, Sales $307.024M Beat $304.695M Estimate Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.70 by 41.43 percent. This is a 22.22 percent increase over earnings of…
benzinga.com 12 Information Technology Stocks Moving In Tuesday's After-Market Session - benzinga.com Earnings Scheduled For November 18, 2025
- benzinga.com Enhancing HDR On Instagram For iOS With Dolby Vision https://engineering.fb.com/2025/11/17/ios/enhancing-hdr-on-instagram-for-ios-with-dolby-vision/
benzinga.com Insights Ahead: Dolby Laboratories's Quarterly Earnings - benzinga.com Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $100 Price Target Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperform and maintains $100 price target.
benzinga.com This Twilio Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday 
benzinga.com Deep Dive Into Dolby Laboratories Stock: Analyst Perspectives (4 Ratings) 
benzinga.com Baird Initiates Coverage On Dolby Laboratories with Neutral Rating, Announces Price Target of $74 Baird analyst Vikram Kesavabhotla initiates coverage on Dolby Laboratories (NYSE:DLB) with a Neutral rating and announces Price Target of $74.
benzinga.com Applied Materials To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - benzinga.com Tigress Financial Maintains Buy on Dolby Laboratories, Raises Price Target to $114 Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:DLB) with a Buy and raises the price target from $112 to $114.
- benzinga.com Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $95 Price Target Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $95 price target.
- benzinga.com Dolby Laboratories Affirms FY2025 Adj EPS Guidance of $3.88-$4.03 vs $3.97 Est; Narrows FY2025 Sales Guidance from $1.31B-$1.38B to $1.33B-$1.36B vs $1.34B Est Dolby Laboratories (NYSE:DLB) affirms FY2025 Adj EPS guidance from $3.88-$4.03 to $3.88-$4.03 vs $3.97 analyst estimate. Narrows FY2025 sales outlook from $1.31 billion-$1.38 billion to $1.33…
- benzinga.com Dolby Laboratories Sees Q4 Adj EPS $0.61-$0.76 vs $0.77 Est; Sees Sales $288.000M-$318.000M vs $310.12M Est Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $0.61-$0.76 vs $0.77 analyst estimate. sees sales of $288.000 million-$318.000 million vs $310.12 million analyst estimate.
- benzinga.com Dolby Laboratories Q3 Adj. EPS $0.78 Beats $0.71 Estimate, Sales $315.55M Beat $305.23M Estimate Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.71 by 9.4 percent. This is a 9.86 percent increase over earnings of $0.71…
- benzinga.com Earnings Scheduled For July 31, 2025
- benzinga.com Deep Dive Into Dolby Laboratories Stock: Analyst Perspectives (4 Ratings)
- benzinga.com Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $95 Price Target Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $95 price target.
- benzinga.com Tigress Financial Maintains Buy on Dolby Laboratories, Lowers Price Target to $112 Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $116 to $112.